Health Care: Drugs

Novogen Ltd (NVGN: NASDAQ)

$2.4 n/a | n/a%
12/24/14 - 12:59 PM ET
Company Income Statement
Jun 2014 Jun 2013 Jun 2012 Jun 2011
Sales 81.91K 1.03M 2.51M 2.16M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 81.91K 1.03M 2.51M 2.16M
Selling, General, and Administrative Expenses 4.02M 2.64M 5.93M 10.22M
Research & Development 2.33M 237.54K 5.53M 4.17M
Operating Income before D & A (EBITDA) -6.27M -1.85M -8.95M -12.23M
Depreciation & Amortization 538.54K 311.78K 25.60K 88.71K
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -186.42K 573.44K 0.00 547.21K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -6.99M -1.59M -8.98M -11.77M
Interest Expense 673.17K 122.48K 0.00 19.24K
Pre-Tax Income -7.66M -1.71M -8.98M -11.79M
Income Taxes 0.00 0.00 0.00 1.07K
Minority Interest -95.09K 228.26K -2.72M -3.19M
Net Income From Continuing Operations -7.13M -1.40M -8.95M -11.70M
Net Income From Discontinued Operations 0.00 670.87K 7.57M 1.57M
Net Income From Total Operations -7.13M -728.40K -1.38M -10.13M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -7.03M -956.67K 1.34M -6.94M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-7.13M -1.40M -8.95M -11.70M
Preferred Dividends
Net Income Available To Common -7.13M -1.40M -8.95M -11.70M
Basic EPS from Continuing Ops. -1.12 -0.31 -1.51 -2.08
Basic EPS from Discontinued Ops. 0.00 0.10 1.84 0.37
Basic EPS from Total Operations -1.12 -0.21 0.33 -1.71
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.12 -0.21 0.33 -1.71
Basic Normalized Net Income/Share -1.12 -0.31 -1.51 -2.08
EPS fr Continuing Ops. -1.12 -0.31 -1.51 -2.08
EPS fr Discontinued Ops 0.00 0.10 1.84 0.37
EPS fr Total Ops. -1.12 -0.21 0.33 -1.71
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.12 -0.21 0.33 -1.71
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.12 -0.31 -1.51 -2.08
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with NVGN

Latest NVGN Headlines from TheStreet

More Financial News for NVGN

Press Releases for NVGN

See All Press Releases

Partner Headlines for NVGN

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter